108 related articles for article (PubMed ID: 6454649)
1. Effects of pulse cyclophosphamide on NZB/W disease.
Chia D; Levy L; Barnett EV; Carnes WH
Immunology; 1981 May; 43(1):57-65. PubMed ID: 6454649
[TBL] [Abstract][Full Text] [Related]
2. Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactants.
Cavallo T; Graves K; Granholm NA
Clin Exp Immunol; 1984 Jan; 55(1):67-73. PubMed ID: 6607142
[TBL] [Abstract][Full Text] [Related]
3. Clonality of the spontaneous immune response to DNA in murine lupus.
Cavallo T; Granholm NA; Graves K; Izui S
J Clin Lab Immunol; 1986 Jun; 20(2):81-7. PubMed ID: 3488408
[TBL] [Abstract][Full Text] [Related]
4. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants.
Cavallo T; Graves K; Granholm NA
Lab Invest; 1983 Oct; 49(4):476-81. PubMed ID: 6604840
[TBL] [Abstract][Full Text] [Related]
5. The New Zealand mouse as a model for the therapy of human SLE: immunomodulation of murine lupus by sex hormones and cyclophosphamide.
Papoian R; Roubinian JR; Dauphinée MJ; Talal N
Agents Actions Suppl; 1980; 7():41-5. PubMed ID: 6941685
[No Abstract] [Full Text] [Related]
6. Alteration of lymphocyte function in NZB/NZW mice. IV. Response to levamisole.
Hahn BH; Knotts LL
Arthritis Rheum; 1979 Mar; 22(3):236-42. PubMed ID: 33681
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
8. Long term administration of cyclophosphamide into MRL/1 mice. II. The effects on the isotype of anti-DNA antibodies and immunoglobulin secreting cells in the spleen.
Shiraki M; Fujiwara M
Clin Exp Immunol; 1984 Mar; 55(3):519-24. PubMed ID: 6608425
[TBL] [Abstract][Full Text] [Related]
9. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
[TBL] [Abstract][Full Text] [Related]
10. Theophylline prolongs survival and decreases renal damage in female NZB/W F-1 mice.
Gelber M; Sidi Y; Ben-Bassat M; Shohat B; Pinkhas J; Weinberger A
Thymus; 1988; 11(4):231-41. PubMed ID: 2972091
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response.
Klassen LW; Williams GW; Reinertsen JL; Gerber NL; Steinberg AD
Arthritis Rheum; 1979 Feb; 22(2):145-54. PubMed ID: 33680
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
Carlsten H; Holmdahl R; Tarkowski A
Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
[TBL] [Abstract][Full Text] [Related]
13. Serum immune complexes and disease activity in lupus nephritis.
Levinsky RJ; Cameron JS; Soothill JF
Lancet; 1977 Mar; 1(8011):564-7. PubMed ID: 65659
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of anti-DNA antibodies in murine lupus nephritis.
Granholm NA; Graves K; Izui S; Cavallo T
J Clin Lab Immunol; 1985 Nov; 18(3):113-8. PubMed ID: 3878885
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic trials with levamisole and other agents in NZB/W mice.
Russell AS
J Rheumatol; 1976 Dec; 3(4):380-3. PubMed ID: 1088166
[TBL] [Abstract][Full Text] [Related]
16. [Experimental approach to the pathogenesis of systemic lupus erythematosus].
Lambert PH; Creighton D; Goodman R; Bankhurst A; Mischer PA
J Urol Nephrol (Paris); 1972 Dec; 78(12):973-80. PubMed ID: 4350279
[No Abstract] [Full Text] [Related]
17. The immunopathogenesis of lupus nephritis.
Agnello V
Adv Nephrol Necker Hosp; 1976; 6():119-36. PubMed ID: 65907
[No Abstract] [Full Text] [Related]
18. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
Sato MN; Minoprio P; Avrameas S; Ternynck T
Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
[TBL] [Abstract][Full Text] [Related]
19. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of auto anti-idiotypic antibodies reactive with antibodies expressing the pathogenic idiotype, IdLNF1, in the (NZB x SWR)F1 model for lupus nephritis and its parental strains.
Uner AH; Tatum AH; Knupp CJ; Gavalchin J
J Autoimmun; 1998 Jun; 11(3):233-40. PubMed ID: 9693971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
